Finch Therapeutics Group, Inc.

FNCHOTC· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$107,000

▼ 87.6% YoY

Net Income

-$74.8M

▲ 34.8% YoY

EPS

$-46.59

▲ 35.4% YoY

Cash

$25.1M

▼ 64.6% YoY

FY 2023 · As of 2023-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.